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1  Executive summary 
Aims and background 
 
 The aim of this rapid review is to examine the evidence relating to the benefits, uptake and 
operationalisation of mHealth technologies for chronic disease management and prevention. 
 
 In a context of rapidly emerging technologies, it is important to understand what evidence is available 
to inform policy interventions designed to integrate technology for health service delivery, especially for 
services that are accessed by people of varying socio-economic status (SES). 
 
 For the purpose of this review, mHealth technologies refer to Short Message Service (SMS)/Multimedia 
Message Service (MMS), mobile devices (e.g. Personal Digital Assistant [PDA]), mobile apps, wearable 
devices and sensors. Excluded from this review are telehealth and telephone-based services. 
 




 The majority of studies included in this review were published after 2010, indicating the relative infancy 
of this technology and the need for further evaluation of its long-term effectiveness. 
 
 Of all the mHealth technologies, SMS is the most commonly evaluated in the literature, and that with 
the strongest evidence of effectiveness. 
 
 Evidence for interventions containing more innovative technologies, such as those involving 
smartphone apps and/or wearable devices, has been generated predominately from feasibility and 
usability studies, with few published randomised controlled trials (RCTs) evaluating effectiveness. 
 
 For studies focusing on benefits for self-management, diabetes was the most common chronic disease 
studied. Significant improvements were found in glycaemic control through the use of mobile phones, 
SMS, internet, and/or wireless devices. 
 
 For studies focusing on behaviour change, significant improvements were found in physical activity 
measures, weight loss outcomes, and smoking cessation, among others. 
 
 The evidence regarding socio-economic and demographic factors of mHealth, as well regarding 
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Concluding remarks 
 
 SMS is the most commonly studied mHealth technology, with the strongest evidence of effectiveness. 
 
 mHealth interventions can promote significant improvements in glycaemic control (for diabetes 
patients), as well as in physical activity, weight loss, and smoking cessation, among other outcomes. 
However, benefits appear dependent upon the characteristics of the intervention (e.g. bundle of 
features, use of behaviour change theories) and the specific patient population (e.g. age, digital 
literacy). 
 
 One important marker of the success of an mHealth intervention is its integration into healthcare as 
part of a service (and not as a standalone system). One of the greatest barriers to mHealth uptake in 
healthcare is the existence of competing health system priorities, combined with a lack of evaluation 
studies and cost-effectiveness analysis to guide decisions. 
 
 Improving the uptake and impact of an mHealth service will require the following elements: i) 
integration into a health service, ii) bundles of features to facilitate action (e.g. decision support, 
followed by task support), iii) application of appropriate use of theories and behavioural change 
strategies underpinning program design, iv) strategies employed to maintain participant interest and 
minimise dropout, and v) ensuring mHealth service fidelity (i.e. the accurate delivery, receipt, and 
enactment of the service). 
 
 Strategies to increase uptake of mHealth should address the main barriers for each stakeholder as part 
of this process: payers, providers and, most importantly, patients. 
 
 Relevant to Healthdirect Australia, opportunities may arise in providing personalisation and tailoring 
offered by these emerging mHealth technologies, situating these technologies in the existing 
ecosystem of Healthdirect Australia, and identifying bundles of mHealth and eHealth features that 
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2  Background and introduction 
Chronic diseases are the leading cause of mortality and morbidity worldwide.
1,2
 Patients with a chronic 
condition spend on average one hour per year with their physician, leaving around 10,000 hours where they 
have to manage their health and illnesses by themselves.
3
 Self-management activities involve managing 
symptoms to prevent complications, adhering to treatment regimes, initiating and maintaining lifestyle 
changes and coping with the physical and psychosocial consequences of the disease. All of these activities 
combined have been demonstrated to minimise the deleterious impact of the condition on health.  
 
Further, self-management programs aim to improve the knowledge, skills, and confidence that are 
important for both self-care as well as for increasing linkages with clinical care and improving health 
outcomes.
4-11
 Elements commonly involved in successful self-management and behavioural change 
programs include: education; collaborative problem definition; self-management training and support; 




The advent of the internet and other technologies in recent times has allowed patients access to greater 
amounts of information in order to guide decision making about healthcare.
13-16 
Therefore, interest in the 
use of eHealth to facilitate self-management and promote patient empowerment is rapidly increasing.
17-20 
Among the diversity of eHealth interventions now emerging, mHealth shows particular promise. 
 
Mobile health, or mHealth, may be defined as “the use of mobile telecommunication technologies for the 
delivery of healthcare and in support of wellness”.
21
 Mobile technologies such as mobile phones and wireless 
monitoring devices have many clear benefits that can supplement or extend beyond that provided by 
traditional healthcare delivery platforms: they are popular, readily available, easily portable, have high 




In October 2014, the number of active mobile devices surpassed the world population: 7.22 billion devices.
23
 
In Australia, December 2014 data reveal that 5.2 million adults use only their mobile phone to make calls (i.e. 
they do not have a fixed-line telephone service); 3.9 million adult Australians are mobile-only internet users; 
and 2.1 million are exclusively mobile in their phone and internet communications.
24
 Additionally, the 
Australian Mobile Phone Lifestyle Index survey, carried out at the end of 2014, found that 89% of 
respondents owned a smartphone, and that between 59–80% were high-level users of the mobile phone; 
voice calls, SMS, sending/receiving emails, information gathering, visiting websites and/or browsing and/or 
searching the internet were all enacted via mobile phone.
25
 Furthermore, almost one in five reported 
accessing health and wellbeing information on their mobile phone regularly (at least once a month), and 
27% reported having used ‘health & wellbeing’ apps in the last six months.
25
 These figures are rapidly 
increasing. A Deloitte report revealed the number of mobile device users who downloaded at least one 




Given the growing burden of chronic diseases coupled with the increasing popularity of mobile 
technologies, the application of mHealth in their self-management and primary prevention seems 
promising. mHealth may improve the monitoring and tracking of health behaviours, the collection of health 
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adherence to treatment regimes; all of which have the potential to empower patients with respect to self-




Aims and questions addressed 
 
The aim of this rapid review was to examine the evidence relating to the benefits, uptake and 
operationalisation of mHealth technologies for chronic disease management and prevention. The following 
four questions were explicitly addressed in this review: 
 Question 1: What is the evidence regarding the benefits of using mHealth technologies to support 
chronic disease management? 
 
 Question 2: What is the evidence regarding the benefits of using mHealth technologies to track 
health behaviours for prevention purposes? 
 
 Question 3: What is the evidence regarding how demographic and socio-economic factors affect 
the benefits of mHealth? 
 
 Question 4: What is the evidence regarding strategies that can be used to operationalise the use 
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3  Methods 
Search strategy 
 
A search of the literature from 2005 onwards was performed from September to October 2015 using 
Pubmed, Embase, Scopus, CINAHL and Cochrane library. Search terms included mHealth, chronic diseases, 
and self-management (complete search strategy available in Appendix A).  
 
The reference lists of relevant articles were also screened to ensure all eligible studies were captured. To 
capture grey literature, publications and reports from several institutions (e.g. World Health Organization 
[WHO], Pew Research Centre, IMS Institute for Healthcare Informatics, PricewaterhouseCoopers, The 
Economist) were searched. Key opinion leaders with international standing in the field of mHealth, chronic 
disease management and prevention, and underserved populations were contacted regarding possible 
additional studies that met the inclusion criteria. 
 
To ensure mobile apps from the Australian setting were included in the review, those that were listed by the 
government and non-profit chronic disease groups at the federal and state level were examined. Mobile 
apps developed by non-profit consumer groups in Australia were identified for each chronic disease, as 
indicated by the Australian Institute of Health and Welfare (www.aihw.gov.au/chronic-diseases/). Health-
related apps developed by the Australian government on the federal and state level were also retrieved 
(www.australia.gov.au/about-government/apps). A full list of these apps is outlined in Appendix B.  No 
evaluation studies of these apps were identified at the time of writing.  
 
Study selection criteria 
 
Studies were included in this review if they: 1) focused on patients or consumers; 2) involved a mobile health 
intervention, either isolated or as part of a multi-component intervention; 3) were qualitative or quantitative, 
cross-sectional or prospective in design (however, for aspects pertaining to effectiveness, only experimental 
studies and systematic reviews/meta-analyses were considered); 4) were focused on the self-management 
of a chronic condition, or focused on tracking/promoting health behaviours (e.g. physical activity, diet) or 
reducing behavioural risk factors (e.g. smoking, alcohol/other substances abuse). 
 
Studies were excluded if they: 1) focused exclusively on telemedicine or on the remote management of a 
condition by providers (not involving a self-management component); 2) focused on acute rather than 
chronic conditions; 3) involved a medical intervention (diagnosis or treatment) instead of self-management; 
4) were opinion articles or editorials; 5) were duplicates or were not in English. 
 
Additionally, literature regarding low-income countries was only considered for Question 3, as advised by 
the Commissioning Agency (Questions 1, 2 and 4 focused on middle- and high-income countries). 
Furthermore, for SMS-focused papers, only reviews were included (primary research was excluded, as 
advised by the Commissioning Agency), unless the intervention was deemed innovative in any sense. Finally, 
primary studies were excluded if they were found to have been already included in any of the reviews 
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Initial screening of studies was based on the information contained in their titles and abstracts and was 
conducted by four investigators. Full-paper screening was conducted individually by the same four 
investigators. When there were doubts regarding inclusion or exclusion, another investigator (LL or AL) was 
involved in the decision. 
 
The scope of each question was defined by the Commissioning Agency as follows: 
 
Research Question 1: What is the evidence regarding the benefits of using mHealth technologies to 
support chronic disease management? 
 
Scope of question 1: 
 Benefits include not only direct and measurable benefits to the consumers, such as reduction in 
excess weight or cholesterol levels, but also health literacy, the ability to self-manage, awareness 
and other factors that may indirectly lead to better health. Include also evidence regarding benefits 
that may accrue to parties other than the consumer, if any (for example, a better estimate of the 
prevalence of a certain condition in a specific area would benefit society as a whole). 
 
 Chronic disease management is defined broadly. However, this review does not include the 
management of end stage chronic conditions, such as end stage renal disease (ESRD) that may 
require extensive treatment and/or interaction with the hospital/provider system. 
 
 Include evidence showing the cost-effectiveness of the application, highlighting whichever 
perspective has been used (societal or the perspective of some other stakeholder). 
 
 Include any evidence related to mHealth improving self-reporting by adding actual observations. 
 
Research Question 2: What is the evidence regarding the benefits of using mHealth technologies to 
track health behaviours for prevention purposes? 
 
Scope of question 2: 
 ‘Tracking health behaviours’ may be achieved through the collection information provided by a 
device/biomedical sensor or by allowing users to enter information themselves. 
 
 Include evidence regarding preventive activities related to reduction of behavioural risk factors. 
Natural targets for prevention include, but are not limited to: 
 Physical activity/reduction of sedentary lifestyle   
 Smoking 
 Diet 
 Obesity reduction 
 Alcohol consumption. 
 
 Include evidence regarding whether mHealth applications geared to reduce behavioural risk factors 
(such as those listed above) capture the pattern of risky activities early enough to allow a preventive 
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 Include evidence regarding the prevention of health events that can be avoided if caught early 
enough. Healthdirect Australia already provides an online service called ‘Symptom Checker’ 
(www.healthdirect.gov.au/symptom-checker) that allows individuals to input information about 
their symptoms, receive personalised information and/or possibly be recommended to seek 
medical attention. Include evidence of how mHealth technologies can be used by such a service to 
receive better and more timely information. 
 
 Include evidence showing the cost-effectiveness of the application, highlighting whichever 
perspective has been used (societal or the perspective of some other stakeholder).  
 
Research Question 3: What is the evidence regarding how demographic and socio-economic factors 
affect the benefits of mHealth? 
 
Scope of question 3: 
 Include evidence of the benefits of mHealth, as well as barriers to its use, for Aboriginal and Torres 
Strait Islanders and Culturally and Linguistically Diverse (CALD) populations. 
 
 Include evidence on the effect of health literacy. 
 
 Factors to be considered include, but are not limited to, age, gender, ethnicity, education and 
remoteness/geography. 
 
 Different sub-populations may benefit differently from mHealth because their adoption rates are 
different and/or they respond differently to the intervention. Both perspectives should be included 
in the analysis. 
 
 Highlight what are the documented barriers to the use/adoption of mHealth technologies across 
different sub-populations. 
 
Research Question 4: What is the evidence regarding strategies that can be used to operationalise the 
use of mHealth technologies for chronic disease management and prevention purposes? 
 
Scope of question 4: 
 Assuming that some mHealth technologies with significant benefits have been identified and 
appropriate platforms are in place, how can the technology be brought to consumers and how can 
uptake be increased? What are the next operational steps that need to be taken in order to roll out 
an application? Note that this question is not about the development of an application, which is not 
in the scope of Healthdirect Australia, but rather about the strategies that lead to successfully 
implementing a successful service. 
 
 Include evidence regarding past failures. For example, if an application had been developed and 
was never taken up by consumers, what went wrong? What could have been done differently? 
What lessons were learned? 
 Include evidence regarding past successes. For example, if an application had been developed and 
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 Include evidence regarding factors that can influence the adoption of mHealth technologies and 
what strategies can be used to incentivise and promote adoption. 
 
 Include evidence regarding barriers to the adoption of mHealth, such as privacy concerns, 
conservative culture in healthcare, regulations and other institutional constraints. 
 
Data extraction strategy and synthesis procedures 
 
Four investigators extracted information from the included studies into a standardised computer-based 
form. The following data were collected for each study: first author, year, study type, mHealth mode, 
intervention task, participants and setting, health domain, main findings, and quality assessment. Results 
were grouped by question. When papers covered topics pertaining to more than one question, they were 
included (and data were abstracted) for each of the covered questions. Two investigators (LL and AL) 
reviewed the complete abstraction form for consistency. A narrative synthesis was conducted for the 
included studies. Effect sizes, such as standardised or weighted mean differences, relative risks, odds ratios, 
and z scores, were extracted from meta-analysis. 
 
For the purposes of this analysis, we classified the ‘mHealth mode’ into four main categories: SMS; phone 
plus software or application; phone plus specific instrument (medical device connected to phone via a cord); 
or phone plus wireless or Bluetooth-compatible device. The specific function of the mobile device utilised in 
the intervention was also abstracted, when mentioned by the authors of the study (e.g. 
GPS/camera/scanner/voice recorder). 
 




 Inform: provide information in a variety of formats (text, photo, video, audio) 
 Instruct: provide instructions to the user 
 Record/Track: capture user-entered data 
 Display: graphically display user-entered data/output user entered data 
 Guide: provide guidance based on user-entered information, and may further offer a diagnosis, or 
recommend a consultation with a physician/a course of treatment 
 Remind/Alert: provide reminders to the user 
 Communicate: provide communication with Healthcare Professionals (HCP) (email/SMS)/patients 
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Assessment of evidence quality 
 
The quality of the included studies was assessed in terms of their design.   
 
Literature reviews were classified into:  
 Systematic reviews with a meta-analysis component were considered ‘very high’ on the Grade of 
Quality 
 Systematic reviews without a meta-analysis were generally considered ‘high’  
 Narrative or other forms of reviews that were not conducted with high levels of rigour were 
considered ‘moderate/low’. 
 
Empirical studies were classified into:  
 Technical feasibility or pilot studies. These studies tested the technical feasibility of the mHealth 
interventions, such as algorithm accuracy and efficiency.  They are not clinical studies, and may be 
tested on simulated data.  Often no human participants are involved in these studies.  These studies 
may be conducted with high levels of technical rigour. However, for the purpose of this review, 
these studies were considered ‘low’ on the Grade of Quality as they do not inform how human 
participants would use or benefit from the technology. 
 
 Descriptive/qualitative studies. These studies used focus groups or interviews on usually small 
samples and were generally considered ‘low’ quality. 
 
 Cross-sectional surveys. These studies undertook surveys that prospectively asked patients and 
consumers about factors influencing their use of mHealth, or their attitudes, intentions or 
perceptions of use. Most of these studies were conducted in relation to specific health topics. These 
studies were generally considered to be of ‘low’ quality. 
 
Those studies that conducted multivariate analysis in an attempt to focus on the strongest 
associations with mHealth use were of higher quality, and thus were considered ‘moderate/low’ 
quality in this review. Risk of bias in these studies was assessed by whether the study had discussed 
representativeness of the survey. 
 
 Experimental studies. These studies described and evaluated the effects of an intervention. 
Generally, intervention studies are of higher quality than descriptive/qualitative studies and cross-
sectional surveys. Of these studies, before and after studies, quasi-experimental, or cross-sectional 
comparisons were the weakest design, and thus considered of ‘moderate’ quality.   
 
Randomised controlled trials (RCTs) were the strongest design, and considered of ‘moderate/high’ 
quality in this review. Higher-quality studies also examined actual changes in health outcome and 
behaviours rather than attitudes or intentions as primary outcomes. Risk of bias was assessed in 
terms of the presence and characteristics of a control group and selection bias, as many studies 
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4  Results 
The database search retrieved 4222 citations (Figure 1). After removing duplicates (N=2078), 1894 articles 
were excluded based on their title and abstract, and 250 full-text papers were reviewed. A total of 72 papers 
were included in this review. Several articles covered aspects related to more than one of the four questions: 
21 papers were included in Question 1, 20 in Question 2, 15 in Question 3, and 29 in Question 4. Grey 
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Table 1: Papers included for this review (2005 to current) 
Question References Grade of Evidence 




 22 systematic reviews 
(5 meta-analysis) 
 1 scoping review 
 4 RCTs 
 3 quasi-experimental 
 1 feasibility  
 
 High for SMS 
 Moderate for mobile apps and 
devices 
 Low for wearable and sensors 
Q2. Benefits of mHealth to track 
health behaviours for primary 
prevention purposes 
16 studies: 
 13 systematic reviews 
(6 meta-analysis) 
 1 scoping review 
 2 RCTs 
 
 High for SMS 
 Moderate for mobile apps and 
devices 
 Low for wearable and sensors 
Q3. Socio-economic and 
demographic factors affecting 
mHealth uptake and benefits  
15 studies: 
 4 systematic reviews (2 
meta-analysis) 
 2 scoping reviews 
 2 RCTs 
 1 qualitative 
 1 mixed-methods  
 5 feasibility 
 
Moderate to Low  
Q4. Operationalisation of 
mHealth 
6 grey literature reports 
28 studies: 
 7 systematic reviews 
 1 scoping review 
 2 RCTs 
 3 quasi-experimental 
 8 feasibility 
 1 qualitative 
 1 survey 
 1 case-control 
 4 cross-sectional 
 




MHEALTH TECHNOLOGIES FOR CHRONIC DISEASE PREVENTION AND MANAGEMENT | SAX INSTITUTE 12 
Question 1: What is the evidence regarding the benefits of using mHealth technologies to support 
chronic disease management? 
 
Summary points: 
 In order to evaluate the evidence regarding the benefits of using mHealth technologies to support 
chronic disease management, 21 papers were analysed (published between 2008 and 2015). 
 
 In the analysed publications, the health domains where these mHealth technologies have been 
tested to support chronic disease management were: diabetes, cardiovascular, chronic lung 
diseases (i.e. Chronic Obstructive Pulmonary Disease [COPD], asthma), mental health, and 
osteoarthritis. 
 
 Several mHealth technologies were used: SMSs, mobile or smartphone (with or without internet 
access), PDAs, tablets, handheld computers, apps, blood sugar monitors, blood pressure monitors, 
pedometers, accelerometers, and sensors. The most commonly used mode of delivery was SMS. 
 
 The majority of mHealth interventions to support chronic disease management seem to involve a 
great variety of functions/tasks, such as to inform, instruct, record, display, guide, remind/alert, and 
communicate. 
 
 The majority of studies focused on diabetes (three meta-analyses and 10 systematic reviews). The 
three meta-analyses in patients with diabetes showed improvements in glycaemic control through 
the use of mobile phones, SMS, internet, and/or wireless devices, with moderate effect sizes (-0.60, 
-0.51, and -0.27). The ten systematic reviews of mHealth interventions for diabetes self-
management showed mixed results for the various outcomes assessed (e.g. Body Mass Index (BMI), 
weight, glycaemic control, cholesterol, self-management behaviours, self-efficacy, and exercise). 
 
 The remaining studies, mostly systematic reviews, showed inconsistent results for a variety of 
outcomes across several health conditions. 
 
 The majority of the analysed studies did not take into account the costs associated with 
intervention provision. Only two studies mentioned cost issues; one concluded that the particular 
intervention being provided was not cost-effective (yet this was not based on formal economic 
evaluation). 
 
1.1. Benefits of using mHealth technologies to support chronic disease management:  
1.1.1 Diabetes (type 1 and 2) 
Three meta-analyses
32-34
 on mHealth interventions for type 1 diabetes (T1DM) and/or type 2 diabetes 
(T2DM) self-management were identified, showing significant improvements in glycaemic control for 
patients in the intervention groups compared with controls, with moderate effect sizes (-0.60, -0.51, and -
0.27) (Table 2).  
 
Interestingly, Saffari et al. 2014
32
 reviewed six studies which used SMS to send and receive data (interactive 
approach) relating to Blood Glucose, diet, physical activity, and medication adherence
35
 and showed that 
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unidirectional (only data collection) approaches, as did those using SMS and the internet. Furthermore, 
mHealth technologies for type 2 diabetes were most effective when combined with health care professional 
feedback.  
 
Table 2: Summary effects from meta-analysis of mHealth in diabetes 
Study author, year Number, type and intervention duration 
of included studies 
Summary effect* (standard 
difference in means) 
[95% prediction interval] 
Saffari et al., 2014
32
   10 RCTs 
(3–12 months) 
-0.60 [-0.83; -0.36] 
Liang et al., 2011
33
 22 experimental studies (11 RCTs) 
(3–12 months)  
-0.51 [-0.69; -0.33] 
Free et al., 2013
34
 5 RCTs 
(3–12 months) 
-0.27 [-0.48, -0.06] 
* Effect sizes smaller than zero represent a decrease in the intermediate outcome (e.g. HbA1c), meaning an 
improvement as a result of the intervention. 
 
Ten systematic reviews of mHealth interventions for diabetes self-management showed inconsistent 
results for the various outcomes assessed (e.g. BMI, weight, glycaemic control, cholesterol, self-management 
behaviours, self-efficacy, and exercise). 
 
 Connelly et al. 2013
36
 reviewed 15 studies on T2DM involving eHealth. Among the three studies 
particularly concerning mHealth, there were no significant differences between intervention and 
control groups regarding physical activity or glycaemic control.   
 
 Holtz et al. 2012
37
 reviewed 21 experimental studies on mHealth interventions for T1DM and/or 
T2DM self-management and found that the outcomes assessed varied considerably across studies, 
with few significant findings being reported (three studies reported significant improvements in 
glycaemic control and two studies in knowledge about diabetes). 
 
 Baron et al. 2012
38
 reviewed 24 papers corresponding to 20 experimental studies (13 studies on 
T2DM and seven on T1DM), finding that poor reporting and methodological weaknesses were 
frequent, and that study variability and mixed results hampered an objective assessment of 
benefits. Few statistically significant results were reported. 
 
 Krishna et al. 2008
39
 reviewed 18 papers on diabetes self-management with the use of cell phone 
technology and found that nine out of 10 studies that measured haemoglobin A1c showed a 
significant improvement, but there were mixed results regarding other outcomes. 
 
 Russell-Minda et al. 2009
40
 reviewed 18 trials on cell phone and wireless technologies for diabetes 
self-management and found limited to moderate evidence that interventions using mobile phones 
and wireless devices may improve glycaemic control. 
 
 Hamine et al. 2015
22
 reviewed 107 studies focusing on several health domains and found significant 
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 Buhi et al. 2012
41
 reviewed 34 studies focusing on several health domains and identified six out of 
17 diabetes-related studies where glycaemic control was improved when SMS was utilised. 
 
 De Jongh et al. 2012
42
 reviewed experimental studies focusing on several health domains, including 
diabetes, and found little evidence of benefit. 
 
 Krishna et al. 2009
43
 reviewed 25 studies focusing on several health domains and found significant 
improvements in diabetes-related health outcomes in eight out of nine studies involving diabetes 
patients. 
 
 Allet et al. 2010
44
 found mixed results in the 10 diabetes studies reviewed. 
 
1.1.2 Cardiovascular disease 
Five systematic reviews of mHealth interventions for cardiovascular disease (CVD) showed mixed results for 
the various outcomes assessed (e.g. BMI, weight, lipid profile). 
 
 Hamine et al. 2015
22
 reviewed 107 studies focusing on several health domains and found significant 
improvements in outcomes such as blood pressure (BP), weight, and lipid profile in seven out of 13 
CVD-related studies. Four interventions were designed to improve outcomes for patients with both 
Diabetes Mellitus (DM) and CVD, with half showing significant improvements in clinical outcomes, 
including HbA1c and BP control. 
 
 De Jongh et al. 2012
42
 reviewed one study involving hypertensive patients, which did not find a 
difference in the proportion of patients who achieved blood pressure control, but showed a 
statistically significant difference in adherence to medication. 
 
 Krishna et al. 2009
43
 reviewed one study in hypertensive patients, which did not find statistically 
significant differences in outcomes between intervention and control groups. 
 
 Allet et al. 2010
44
 found mixed results for the five cardiovascular disease studies reviewed. 
 
 Free et al. 2013
34
 reviewed three CVD-related papers: one with unclear/high risk of bias reported an 
improvement in cardiovascular risk profiles for patients receiving telemonitoring via mobile phone 
with text message-based advice; another trial with unclear risk of bias reported a statistically 
significant reduction in systolic and diastolic blood pressure compared to baseline in an 
intervention group receiving monitoring of salt excretion; finally, one trial demonstrated improved 
quality of life for patients with heart failure receiving a mobile phone-based telemonitoring 
intervention. 
 
 Chow et al. 2015
45
 conducted an RCT where patients with coronary heart disease received four 
semi-personalised SMSs per week for six months. At six months, levels of LDL-C were significantly 
lower in intervention participants, with concurrent reductions in systolic blood pressure and BMI, 
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1.1.3 Chronic lung disease  
Seven systematic reviews and one RCT of mHealth interventions for chronic lung disease (CLD) patients 
showed mixed results for the various outcomes assessed: 
 
 Hamine et al. 2015
22
 reviewed 107 studies focusing on several health domains and found mixed 
results in CLD clinical outcomes – three out of six RCTs reported statistically significant 
improvements in lung function parameters. 
 
 Buhi et al. 2012
41
 reviewed one study focusing on asthma which found significant improvements 
between groups. 
 
 De Jongh et al. 2012
42
 reviewed one study involving asthma patients receiving a text messaging 
intervention that showed greater improvements on peak expiratory flow variability (mean 
difference (MD) -11.12, 95% confidence interval (CI) -19.56 to -2.68) and pooled symptom score 
comprising four items (cough, night symptoms, sleep quality, and maximum tolerated activity) (MD 
-0.36, 95% CI -0.56 to -0.17) compared with the control group. 
 
 Krishna et al. 2009
43
 found one asthma study where results showed significantly greater 
improvements in asthma cough and night-time symptoms in intervention patients. 
 
 Allet et al. 2010
44
 found mixed results in four COPD studies. 
 
 Belisario et al. 2013
46
 reviewed two studies on mHealth interventions for asthma self-management. 
One study found no statistically significant differences on asthma symptom scores, asthma-related 
quality of life, visits no the ED or hospital admissions. The other study found statistically significant 
improvements in asthma-related quality of life, lung function, and number of visits to the 
Emergency Department (ED). 
 
 Free et al. 2013
34
 reviewed six studies focusing on asthma control: two trials reported no statistically 
significant beneficial effects of either a text message-based intervention or a mobile phone-based 
monitoring and feedback intervention on asthma control; one trial providing asthma patients with 
alerts regarding health-risk weather forecast had no statistically significant benefits on reducing 
exacerbations of asthma; one trial reported improved quality of life with a mobile phone-based 
asthma self-care system; and another trial reported increases in self-reported adherence to asthma 
medication. 
 
 One multi-centre RCT on mHealth monitoring did not find significant improvement in asthma 
control. Among 288 adolescents and adults with poorly controlled asthma, the mobile technology 
did not improve asthma control or increase self-efficacy compared with paper-based monitoring 




 Finally, an appraisal of available apps for asthma self-management conducted in 2012 found that 
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1.1.4 Mental health 
Four studies (three systematic reviews and one RCT) on mHealth interventions for mental health patients 
found mixed results for a variety of outcomes: 
 
 Ehrenreich et al. 2011
49
 reviewed three studies that used handheld computers targeting anxiety, 
finding significant improvements in anxiety in only one study. 
 
 Donker at al. 2013
50
 reviewed eight papers describing five apps targeting depression, anxiety, and 
substance abuse. No statistically significant differences between intervention and control groups 
regarding depressive symptoms, stress, anxiety, and substance use. Few significant results at follow-
up within the intervention group in several of the studies. 
 
 Free et al. 2013
34
 evaluated four trials focusing on mental health, with mixed results: two trials 
reported increases in emotional self-awareness in young people receiving risk assessment and 
management of youth mental health problems; another trial reported that delivering cognitive 
behavioural therapy messages by mobile phone was feasible and acceptable; finally, one trial 
reported improved recall of goals in interventions delivering text messages to patients undergoing 
brain rehabilitation. 
 
 Depp et al. 2015
51
 conducted an RCT with 82 patients with bipolar disorder. They found that 
patients receiving psychoeducation in intervention group (smartphone) reduced depressive 
symptoms at 12 weeks compared to control group (paper-and-pencil). However, the effect was not 
maintained at 24 weeks. 
 
1.1.5 Medication adherence 
Two meta-analyses
34,52
 found statistically significant results for vaccine attendance and medication 
adherence, respectively (Table 3). 
 
Table 3: Summary effect from meta-analysis of mHealth interventions for medication adherence 
Study author, year Number of studies combined, type and 
intervention duration  
Summary effect (RR) 
[95% prediction interval] 
Free et al., 2013
34
 2 RCTs 
(9–28 days) 
1 [0.77, 1.3] 
 (Medication adherence) 
3 RCTs 
(4 months) 
1.36 [1.27, 1.47] 
(Vaccine attendance) 
Finitsis et al., 2014
52
 9 RCTs 
(14 days to 12 months) 
1.39 [1.18, 1.64] 
(Medication adherence) 
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Six systematic reviews found mixed results for medication adherence, and one RCT did not find a 
statistically significant difference: 
 
 Park et al. 2014
53
 reviewed 29 papers and found that 18 showed improvements in medication 
adherence rates after interventions involving the use of text messages (p < 0.05). 
 
 Anglada-Martinez et al. 2015
54
 found improvements in medication adherence in four of the five 
studies on HIV-infected patients, in eight of the studies on patients with other chronic diseases, and 
in one study performed in healthy individuals. 
 
 Nglazi et al. 2013
55
 found mixed results on the effectiveness of SMS interventions for improving 
patients’ adherence to tuberculosis treatment. 
 
 Mbuagbaw et al. 2015
56
 found mixed results but concluded that there appears to be some benefit 
of using text messaging as a tool to improve adherence to medication and attendance at scheduled 
appointments. 
 
 Hamine et al. 2015
22
 found that of the 27 RCTs that measured the effect of mHealth on adherence 
behaviours, a significant difference between intervention and control groups was observed in 15 
studies. 
 
 Free et al. 2013
34
 reviewed three trials which reported statistically significant increases in adherence 
to antiretroviral medication with text message reminders, and one trial which reported increases in 
adherence that were not statistically significant. 
 
 Cocosila et al. 2009
57
 conducted an RCT on improving adherence to vitamin C with a mobile phone 
intervention and did not find a statistically significant difference between intervention and control 
groups in medication adherence. 
 
1.1.6. Other health domains 
 Allet et al. 2010
44
 reviewed two studies in arthritis patients which showed significant improvements 
in daily step counts between intervention and control groups. 
 
 Heron et al. 2010
58
 evaluated the effectiveness of momentary ecological interventions and found 
mixed results from moderate-low quality studies on the effectiveness of ambulatory treatment for 
smoking cessation, weight loss, anxiety, diabetes management, eating disorders, alcohol use, and 
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1.2 Cost-effectiveness 
Three studies (one RCT, one quasi-experiment, and one feasibility study) have incorporated a quantitative 
approach to analyse costs of mHealth for chronic disease management: 
 
 In an RCT of mobile monitoring that did not find a significant improvement in asthma control, the 
mean cost of providing respiratory care (including the nurse monitoring reviews) was £246 
(standard deviation [SD] £226) in the mobile group compared with £245 (SD £201) in the paper 




 A quasi-experiment examined the fees patients with COPD would be willing to pay for a ubiquitous 
healthcare service. The average acceptable fees (in USD) of the service system are as follows: u-
health device, $421.28; home visit, $21.53/visit; tele-education, $0.53/min or $26.57/month; and 




 A feasibility study estimated T1DM patients would need to pay €10 per month for a data bundle on 
their mobile phone contract in order to use a mobile-enabled application to enter diabetes-related 




Other cost issues were mentioned in the following contexts: 
 
 There is lack of cost-effectiveness analyses with respect to mobile technology as a modality for 




 Few studies take seriously the issue of cost. In many of the small pilot studies, expensive devices or 
vouchers were given to study participants. When implemented at scale, interventions that use 
patients’ existing mobile devices rather than relying on gifted devices will go further toward 




 Rigorous cost-effectiveness analyses will be necessary to demonstrate not only the health impact 




1.3 mHealth and self-reporting 
Three experimental studies evaluated the potential of mHealth to improve self-reporting in chronic disease 
patients, showing positive results: 
 
 Berke EM et al. 2011
61
 conducted a quasi-experimental study with eight participants on self-
tracking using wearable device with sensors to assess sociability and physical activity (e.g. steps 
taken, time spent with others). They found that mobile sensing of sociability and activity was well 
correlated with traditional measures (surveys). 
 
 Garcia-Palacios et al. 2014
62
 conducted an RCT with 47 patients with chronic pain/fibromyalgia and 
found that those with access to a smartphone diary reported more accurate and complete pain 
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 Palmier-Claus J et al. 2012
63
 conducted a quasi-experimental study with 44 participants with 
schizophrenia and related disorders for assessment of psychosis. They found that use of a 
smartphone achieved a compliance of 82% in self-reporting of psychotic symptoms. These 
ambulant ratings showed excellent test-retest reliability scores. 
 
Question 2: What is the evidence regarding the benefits of using mHealth technologies to track 
health behaviours for prevention purposes? 
 
Summary points: 
 Evidence on the efficacy of mHealth interventions to track and promote healthy lifestyle behaviours 
is growing. Three meta-analysis of interventions involving SMS, mobile apps, PDAs, and remote or 
web 2.0 technologies showed significant improvements in physical activity measures and/or weight 
loss outcomes. Two meta-analyses evaluated the effectiveness of mobile phone interventions for 
smoking cessation and found significant results. One meta-analysis combined studies for separate 
outcomes, namely two RCTs for medication adherence and three RCTs for vaccine attendance, 
having found statistically significant results for the latter. 
 
 mHealth technologies utilised for prevention purposes include (in descending order of frequency): 
SMS, apps, self-tracking devices, wearable devices, then sensors. 
 
 Use of SMS to improve health behaviour may be divided into three categories: sending information 
to people (e.g. educating, notifying reminding); gathering information from people; communication 
and interaction. 
 
 Bundle of features is important to achieve behaviour change (e.g. self-monitoring, followed by 
personalised feedback, etc). Most interventions employ feature bundles, not reliant on only one 
feature, which makes the evaluation of their effect more complex. 
 
 Seven systematic reviews included studies where behaviours were tracked with the use of sensors 
and other wireless self-tracking devices (Free, Fanning, Lyzwinski, O’Reilly, Bacigalupo, Bort-Roig, 
Buhi). However, it is not easy to objectively assess the effect of these technologies, for two main 
reasons: most interventions involved several other aspects in addition to wireless self-tracking; most 
systematic reviews did not provide separate analysis for primary studies involving these kinds of 
technologies. 
 
 Behaviour change techniques/theories are not consistently applied in these mHealth interventions. 
There is little integration with clinical care. Drop-off in use over time is common. 
 
 Features in an mHealth intervention that are important for uptake and impact include: tailoring and 
personalisation, being integrated in a health system (and not a standalone system), interactive, 
offering a bundle of features that facilitate behaviour change, use of theories or proven behavioural 
change strategies, and consideration of mHealth treatment fidelity strategies. 
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Weight and physical activity 
Three meta-analyses
64-66
 of interventions involving SMS, mobile apps, PDAs, and remote or web 2.0 
technologies showed significant improvements in physical activity measures and/or weight loss (e.g. step 
counts, duration of moderate to vigorous physical activity, accelerometer counts per minute, self-reported 
physical activity), as well as mixed results for various other outcomes (Table 4). Another meta-analysis
34
 
found no statistically or clinically significant changes in weight for trials using SMS messages to reduce 
calorie intake and increase physical activity (standard mean difference [SMD] 22.14 [95% CI 27.05 to 2.77] 
kg) or for trials using application software to reduce calorie intake (SMD 20.10 [95% CI 20.49 to 0.69] kg) 
(Table 4). There were mixed results for other outcomes in these studies. Finally, one other meta-analysis
67
 
analysing activity monitor-based interventions in patients with type 2 diabetes found statistically significant 
improvements in physical activity, HbA1c, BMI and systolic blood pressure, with small to moderate effect 
sizes (Table 4). 
 
Table 4: Summary effects from meta-analyses of mHealth interventions for physical activity (PA) and/or 
weight loss 
Study author, year Number of studies combined, type and 
duration  
Summary effect (standard 
difference in means [SDM]) 
[95% prediction interval] 
Fanning al., 2012
64
 11 RCTs 
(2–52 weeks) 
0.54 [0.17, 0.91] 
(physical activity) 
Foster et al., 2013
65
 9 RCTs 
(12 months) 
0.2 [0.11, 0.28] 
(physical activity) 




11 RCTs 0.43 [0.25, 0.61] 
(weight change) 
Free et al., 2013
34
 2 RCTs 
(4 weeks) 
[SMS to reduce calorie intake and increase 
physical activity] 




(apps to reduce calorie intake) 
0.10 [-0.49, 0.69] 
(weight change) 





in patients with type 
2 diabetes) 
8 RCTs 0.81 [0.46, 1.17] 
(physical activity) 
16 RCTs -0.23 [-0.41, -0.05] 
(HbA1c) 
10 RCTs -0.24 [-0.48, -0.01] 
(BMI) 
11 RCTs -0.18 [-0.34, -0.01] 
(systolic blood pressure) 
* Effect sizes smaller than zero for weight change, HbA1c, BMI and systolic blood pressure represent an 
improvement as a result of the intervention. Effect sizes above zero for physical activity represent an 
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Seven systematic reviews analysed physical activity and/or weight loss outcomes, having found mixed 
results: 
 
 O’Reilly et al. (2013)
68
 reported that of the 12 included studies that used mobile technologies to 
influence physical activity behaviour, nine reported significant changes in either physical activity or 
sedentary behaviour.  
 
 Bacigalupo et al. (2012)
69
 reviewed 21 RCTs and found consistent evidence that weight loss occurs 
in the short-term as a result of mobile technological-based interventions in overweight and obese 
individuals, with moderate evidence for the medium-term. 
 
 Shaw et al. 2012
70
 found that of the 14 interventions included in the review, 11 showed a 
statistically significant effect on weight loss, diet or exercise, and one study showed a statistically 
significant effect on BP. There were mixed results regarding self-efficacy and social support. 
 
 Stephens et al. 2013
71
 found that five out of the seven studies reported statistically significant 
results in at least one outcome. However, studies were low to moderate in quality and the majority 
of significant findings were not between intervention and control groups and not in the primary 
outcome. 
 
 Bort-Roig et al. 2014
72
 reviewed 17 studies, of which five assessed physical activity intervention 
effects, showing mixed results. Four studies (three pre–post and one comparative) reported physical 
activity increases. 
 
 Buhi et al. 2012
41
 reviewed four studies focusing on weight loss, where three found statistically 
significant results favouring the intervention; mixed results for physical activity.  
 
 Krishna et al. 2009
43
 reviewed one study focusing on physical activity and found a statistically 




 using mobile phone and sensors showed positive results for weight loss in the 
intervention group at 24 weeks. 
 
Smoking cessation and substance use 
Two meta-analyses evaluated the effectiveness of mobile phone interventions for smoking cessation (one 
of the included studies was pooled in both) (Table 5). One meta-analysis
34
 found that SMS-based smoking 
cessation interventions more than doubled biochemically-verified smoking cessation at six months (pooled 
effect estimate relative risk [RR] 2.16 [95% CI 1.77 to 2.62, p<0.0001]). Another meta-analysis was conducted 
by the Cochrane group and studies were pooled in two different analysis, both showing statistically 
significant improvements: one including studies where interventions were delivered solely by mobile phone, 
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Table 5: Summary effect from meta-analysis of mHealth interventions for smoking cessation 
Study author, year Number of studies combined, type and 
duration  
Summary effect (RR) 
[95% prediction interval] 
Free et al., 2013
34
 2 RCTs 
(6 months) 
2.16 [1.77, 2.62] 
(smoking cessation) 






(mobile phone-only intervention) 




(mobile phone and internet intervention) 
2.03 [1.4, 2.94] 
(smoking cessation) 
* Effect sizes higher than one for smoking cessation and abstinence represent an improvement as a result of 
the intervention. 
 
Two systematic reviews and one RCT also focused on smoking cessation outcomes, finding good-quality 
evidence of the effectiveness of mHealth intervention. 
 
 Buhi et al. 2012
41
 found that seven out of eight studies focusing on smoking cessation revealed 
statistically significant differences in smoking cessation. 
 
 Krishna et al. 2009
43
 reviewed four smoking cessation studies which reported significantly greater 
success in behaviour change among the intervention group participants who received a smoking 
cessation–related educational intervention delivered to their cell phones. 
 
 Vidrine et al. 2006
75
 conducted an RCT with HIV patients that showed that participants who 
received the cellular telephone intervention were 3.6 times (95% confidence interval, 1.3-9.9) more 
likely to quit smoking compared with participants who received usual care (P>0.0059). 
 
Other health behaviours 
 Heron et al. 2010
58
 evaluated the effectiveness of momentary ecological interventions and found 
mixed results from moderate-low quality studies on the effectiveness of ambulatory treatment for 
smoking cessation, weight loss, anxiety, diabetes management, eating disorders, alcohol use, and 
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Question 3: What is the evidence regarding how demographic and socio-economic factors affect the 
benefits of mHealth? 
 
Summary points: 
 Few studies have assessed the benefits of mHealth interventions for specific sub-populations. We 
found four studies in diabetes and one in hypertension where this issue was considered. Although it 
seems that younger type 2 diabetes patients, with shorter diabetes duration, may benefit more 
from mHealth interventions, more studies are needed for definitive conclusions to be drawn. 
 
 The most common aspects influencing adoption and use of mHealth technologies reported in the 
literature, include the following: cost, access to the technology/internet, ease of use, perceived 
benefit, computer/mobile phone experience, literacy, level of personalisation/tailoring of the 
intervention, presence of feedback from healthcare providers, convenience, technical problems, and 
security issues. 
 
 Studies in Australian sub-populations, although few, seem to suggest high acceptability and usage 
of the technologies. 
 
 It appears that mHealth tools are acceptable and feasible for most sub-populations as long as they 
are personalised and suited to their different needs, and sufficient training and support are 
provided. 
 
 Adoption and usage may be improved when the design of the intervention takes into consideration 
the particular characteristics and needs of the target population. For instance, to facilitate usage by 
low literacy populations, mobile tools that are based on alternative input mechanisms such as 
photographs and voice can be used instead. Likewise, larger device screens could make mHealth 
tools easier to be used by the elderly. 
 
3.1 Benefits for different sub-populations 
Few studies have assessed the benefits of mHealth interventions for specific sub-populations. We found 
four studies in diabetes and one in hypertension where this issue was considered. 
 
Diabetes 
In patients with diabetes, higher effect sizes were found for younger versus older patients (>55 years old), 
shorter duration of disease, and for type 2 versus type 1 diabetes: 
 
 Saffari et al.
32
 reviewed 10 RCTs on T2DM self-management and showed that the effect size found 
in younger patients [SDM -0.65; Standard Error (SE) 0.119] indicates a higher reduction in HbA1c 
than in patients over age 55 years (SDM -0.42; SE 0.08; p=0.006]. As a possible explanation, at the 
initial stages of risk recognition the person may be more likely to adopt preventive measures to 
avoid complications and negative outcomes related to the risk. 
 
 Baron et al.
38
 reviewed 24 experimental studies and found one where a significant reduction in 
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 Liang et al.
33
 showed in a subgroup analysis that the pooled reduction in HbA1c from 10 studies of 
patients with T2DM was 0.8% [9 mmol⁄mol; 95% confidence interval, 0.5–1.1% (6–12 mmol⁄mol)] 
and the pooled result from nine studies of patients with T1DM was 0.3% (3 mmol⁄mol; 95% 
confidence interval, 0–0.5% (0–6 mmol⁄mol); p for difference = 0.02). 
 
Furthermore, the efficacy of mHealth interventions on diabetes management may be affected by gender, as 
suggested by a qualitative study where men and women differed in regards to self-efficacy, knowledge 





In the subgroup of intervention patients with low literacy or high information needs there was an 8.8mm Hg 
reduction in average systolic blood pressure, and a significantly greater proportion of intervention than 




3.2 Australian studies 
We found three studies conducted in Australia: 
 
 In a study on Aboriginal children with chronic otitis media, it was found that phone multimedia 
messages (MMS) did not have any significant increase in clinical attendance and ear health.
78
 
However, 84% in the control group and 70% in the intervention group were happy to receive phone 
MMS health messages in the future. So, although the difference was not significant, results show 
that MMS is an acceptable and culturally appropriate form of health promotion for these 
Indigenous families. 
 
 One study investigated the acceptability of mHealth interventions by mental health patients, for 
self-management of their conditions. Attitudes toward the use of mobile phones for the monitoring 
and self-management of depression, anxiety, and stress appear to be positive as long as privacy 
and security provisions are assured, and as long as the intervention is not intrusive and is easy to 




 One other study evaluated the feasibility of using an mHealth intervention for cardiac rehabilitation 




Furthermore, one additional study reviewed the evidence regarding the use of social media and mobile 
apps for health promotion in Australian Indigenous populations, having found little evidence pertaining to 




3.3 Barriers to adoption and use by different sub-populations 
The most common aspects influencing adoption and use of mHealth technologies reported in the literature, 
include the following
22,31,79,82-85
: cost, access to the technology/internet, ease of use, perceived benefit, 
computer/mobile phone experience, literacy, level of personalisation/tailoring of the intervention, presence 
of feedback from healthcare providers, convenience, technical problems, and security issues. 
 
The adoption of mHealth technologies requires some level of literacy that needs to be considered especially 
when the interventions are targeting elderly or individuals with lower technical skills.
86
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study, less engagement in an mHealth intervention was observed in racial/ethnic minorities, older adults, 




Nevertheless, studies focusing on use of mHealth tools by vulnerable, hard-to-reach, or high-risk patient 
populations (elderly patients, members of minority ethnic and racial groups and low-income adults) found 
that these tools could lessen the burden of traveling to the healthcare provider’s office.
22
 Also, these 




One review of mHealth interventions for elderly patients found that mHealth is being increasingly used as a 
way to support health management and self-monitoring in this population, but elderly people still face 
some barriers to their current use
84
. Indeed some studies suggest that using specific designs such as larger 




In conclusion, mHealth may help reduce barriers to care and reduce health disparities among different 
groups if inequalities are taken into account in the design of interventions. Further research is needed to 
better understand differences in usability between diverse patient groups and to encourage development of 




Question 4: What is the evidence regarding strategies that can be used to operationalise the use of 
mHealth technologies for chronic disease management and prevention purposes? 
 
Summary points: 
 Strategies to increase uptake of mHealth will likely need to address the main barriers for each of 
the stakeholders in this process: payers, providers and, most importantly, patients. 
 
 Regarding apps, several aspects will be important to facilitate their uptake: payer and provider 
recognition of the potential role of apps in healthcare; creation of security/privacy guidelines and 
policies that protect personal health information; reimbursement and supporting policies; 
integration of apps with other health IT systems; curation and evaluation of healthcare apps to 
guide both patients and clinicians and an infrastructure for app prescribing (i.e. an ‘app formulary’). 
 
 Intervention features associated with increased satisfaction and/or adherence include: interactive 
approaches, user-friendliness, time required to use the application, automatic and wireless 
transmission of data from wearables and other devices, variety of educational and motivational 
content with tailored or personalised SMS, automated reminders, and SMSs with educational and 
motivational content. 
 
 The ‘stickiness of the app’ is an important factor in keeping interest over time and in avoiding the 
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4.1. Operational steps and strategies to increase uptake  
A survey conducted in 2009 by the World Health Organization’s (WHO) Global Observatory for eHealth 
assessed the status of mHealth in Member States, namely the adoption, types of initiatives, status of 
evaluation, and barriers to implementation.
31
 In this survey, completed by 114 Member States, ‘competing 
health system priorities’ was consistently rated as the greatest barrier to mHealth adoption.
31
 Given the 
growing challenges and limited budgets in healthcare today, the selection of interventions is increasingly 
based on evidence of efficacy and cost-effectiveness. However, evaluation studies of mHealth interventions 
are still sparse, and often lack a cost-effectiveness analysis. Indeed, the same 2009 WHO survey found that 
only 12% of Member States reported evaluating mHealth services.
31
 Other barriers to mHealth 
implementation mentioned in the WHO survey included the lack of knowledge concerning the impact on 




For physicians, additional barriers have been mentioned in the literature, such as lack of compatibility with 





For patients, barriers for mHealth uptake include cost, lack of relevant applications, providers’ unwillingness 





On the other hand, drivers for mHealth uptake for patients involve aspects like reducing own healthcare 
costs, convenient access to provider, ability to obtain information, and greater control over own health.
28 
For 
physicians, drivers for uptake include: lower overall cost of care for patients, easier access of patients to care, 
reaching previously unreachable patients, improved quality of care, and more efficient care processes.
28
 
Strategies to increase uptake of mHealth will likely need to address the main barriers for each of the 
stakeholders in this process: payers, providers and, most importantly, patients. Importantly, these strategies 
should also stem from the main drivers for mHealth uptake, identified in the literature.  
 
Key steps for implementing an mHealth project have been described as follows
30
: 1) identifying a clinical 
champion and project team; 2) engaging key decision makers early in the project; 3) developing a project 
outline (including scope, target patient population and target patient volume for the project; key metrics 
and success criteria; product requirements; approval processes; and timeline); 4) mapping the workflow and 
planning the implementation; 5) gathering patient feedback; 6) community building and staff training; 7) 
going live; 8) iterating and monitoring success; and 9) transitioning to long term adoption. 
 
Within mHealth, apps are gaining particular interest, despite their recent appearance. The app maturity 
process will probably be driven by several factors
27-29,90
: payer and provider recognition of the potential role 
of apps in healthcare; creation of security/privacy guidelines and policies that protect personal health 
information; reimbursement and supporting policies; integration of apps with other health IT systems; 
curation and evaluation of healthcare apps to guide both patients and clinicians and an infrastructure for 
app prescribing. This infrastructure, or ‘app formulary’, could facilitate app selection and uptake by grouping 
apps by type and by having ratings of functionality, ease of use, and quality of the content. Three examples 
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 In 2013 the National Health Service (NHS) Commissioning Board in the UK launched a library of 
NHS-reviewed health apps for consumers (e.g. apps providing advice on specific medical conditions 
or allowing users to book repeat prescriptions, access test results, and find the most appropriate 
NHS service).
27
 This library is a response to the overwhelming number of health apps that are 
available nowadays, and is intended to guide users and help them know which ones are safe. 
 
 Companies like HealthTap in the US are also getting involved in the app evaluation market, with a 
product called AppRx, which enables physicians in the network to review health and medical apps 
based on three questions: 1) Is the app medically sound?; 2) Is the app useful?; and 3) Is the app 




4.2. Features influencing adoption 
Intervention features influencing adoption varied across studies and health domains. 
 
In general, features such as automated reminders, SMSs with educational and motivational content, and 





One systematic review found that mHealth studies reporting negative results in adherence were using more 
basic and repetitive content; while the successful studies use several educational and motivational strategies 





Saffari et al. 2014
32
 found that interactive approaches were more effective in improving glycaemic control, 
showing a higher effect size (SDM -0.60; SE 0.08) than unidirectional (data collection-only) approaches (SDM 
-0.31 SE 0.1; p=0.001).  Similarly, SMS plus internet interventions were more effective (SDM -0.87; SE 0.29) 
than SMS-only approaches (SDM -0.44 SE 0.12; p=0.01). 
 
Chomutare et al. 2011
91
 found that although the evidence-based recommendations and requirements 
suggest the use of personalised education and decision-support features in mHealth, most of the diabetes 
mobile apps do not have it integrated. 
 
Liang et al. 2011
33
 found that studies where the intervention used both mobile phone and internet showed a 
greater reduction in HbA1c than the studies with only mobile phone [0.7% (7 mmol⁄mol) vs. 0.4% (4 
mmol⁄mol)], and studies with daily intervention frequency reported greater reduction in HbA1c than those 
with weekly intervention frequency [0.6% (7 mmol⁄mol) vs. 0.2% (2 mmol⁄mol)], but the differences were not 
statistically significant. 
 
Connelly et al. 2013
36
 found that use of additional components within the technology, such as email and log 
books, seemed to increase engagement with the intervention. 
 
Other authors have mentioned ‘ease of use’ and ‘data presentation’ as important aspects for intervention 
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Finally, a review of available apps for diabetes self-management was conducted in 2011, where 137 apps 
were assessed for their functionalities and adherence to evidence-based guidelines, with its results showing 









An analysis of wireless devices (electronic activity monitors) found that all monitors provided tools for self-
monitoring, feedback, and environmental change. Other prevalent techniques were goal-setting and 




Another study has mentioned that the five recommended key components for effective technology-based 
weight loss interventions are self-monitoring, counsellor feedback and communication, social support, use 




Fanning et al. 2012
64
 found significant moderate to large effect for pedometer steps (g=1.05, 95% CI 0.75 to 
1.35, P<0.01). When examining intervention components specifically, those delivered via mobile phone 
yielded a significant moderate effect (g=0.52, 95% CI 0.11 to 0.94, P=0.01). 
 
Foster et al. 2013
65
 found that the most effective interventions applied a tailored approach to the type of PA 
and used telephone contact to provide feedback and to support changes in PA levels. There were no 
differences in effectiveness between studies using different types of professionals delivering the intervention 
(for example health professional, exercise specialist). There was no difference in pooled estimates between 
studies that generated the prescribed PA using an automated computer program versus a human, neither 
between studies that used pedometers as part of their intervention compared to studies that did not. 
 
O’Reilly et al. 2013
68
 found that responses for usability were mixed, varying from 58% of participants 
agreeing that a mobile journal was easy to use  to all participants agreeing that an on-body sensing system 
was easy to use. The studies that reported acceptability assessment outcomes revealed that on-body 
sensing systems, mobile journals, and SMS messaging, received positive acceptability ratings from 
participants. Additionally, one study that used a mobile journal and three studies that used SMS messaging 
determined that these mobile technologies are feasible ways to deliver PA interventions. None of the 
studies that employed on-body sensing systems assessed feasibility, so the literature does not provide 
evidence of the feasibility of on-body systems for PA measurement or interventions. Text messaging or 
smartphone applications are well accepted by participants. Of the 12 studies that used mobile technologies 
to influence PA behaviour, nine (75%) reported significant changes in PA or sedentary behaviour. These 
studies employed SMS communication to promote PA, PA self-monitoring through mobile journaling, or 
both SMS and journaling.  
 
Lyzwinski et al. 2014
66
 concluded that mobile devices appear to induce positive changes in the behavioural 
determinants of weight and subsequently are associated with weight loss. Mobile device interventions were 
heavily informed by theory and behaviour change techniques. All studies included goal setting, self-
monitoring, and feedback. Feedback was provided through different sources of media such as web groups, 
social networking sites, app feedback on the smartphone dashboard, and phone call feedback. Self-
monitoring of diet and physical activity was also employed using various mediums including the use of 




29 MHEALTH TECHNOLOGIES FOR CHRONIC DISEASE PREVENTION AND MANAGEMENT | SAX INSTITUTE 
Shaw et al. 2012
70
 reviewed seven studies which measured feasibility and acceptability of SMS as a mode for 
weight loss interventions. Feasibility was defined as the ability to transmit data via SMS to participants, the 
receipt of information by participants and the ability to communicate back to the researchers. SMS was 
found feasible and acceptable in all seven studies. They also concluded that one SMS per day may be 
appropriate in helping motivate people to engage in weight loss behaviours without generating a 
considerable burden. 
 
De Leon et al. 2014
96
 found that periodic messaging has positive short-term effects across a number of 
health behaviours and across media and frequency. Given that the included interventions varied by many 
factors, including behaviour, prompt, use of feedback, goal-setting, and theoretical models, it was difficult to 
form a conclusive judgment regarding which combination of elements is most effective.  
 
Carter et al. 2013
97
  achieved high trial retention (93%) in the smartphone group, 19 out of 42 (55%) in the 
website group, and 20 out of 43 (53%) in the diary group at six months. Adherence was statistically 
significantly higher in the smartphone group with a mean of 92 days (SD 67) of dietary recording compared 
with 35 days (SD 44) in the website group and 29 days (SD 39) in the diary group (P<0.001). 
 
Medication adherence 
Hamine et al. found that use of daily SMS reminders for medication intake showed significant improvements 
in medication adherence rates.
22
 Text messaging providing education and motivational support were 
associated with improved adherence to medication, namely in patients with diabetes.
22
 One study 
demonstrated the dual benefits of both better access to patient data and mobile coaching.22 One of the 
studies reviewed by the same authors involved the use of an electronic blister pack with SMS 




Other reviews have found that positive studies seem to deliver a variety of educational and motivational 




Ecological momentary intervention (EMI) sessions seem to be viewed by patients as helpful, user-friendly, 
and engaging. Patients report satisfaction with the timing and burden of sessions, as well as the method of 





In one study, patients rated mHealth positively and considered that it may help clinicians to provide care, 
especially during acute attacks. Although rated similarly, professionals were more sceptical about benefits. 
Both professionals and patients had concerns about the time and cost implications.
47
 Also, participants 
considered that mobile phone-based monitoring systems can facilitate guided self-management although, 




Smoking cessation and substance abuse 
A review of 47 iPhone apps available for smoking cessation showed that most apps were found to have low 
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Dulin et al. (2014)
100
 evaluated the effect of a smartphone program for self-management of alcohol usage. 




One important step in improving healthcare for elderly patients using mHealth will be not only to increase 
smartphone penetration in this group, but also to consider family and caregivers of the elderly and the role 
they can play in managing care.
27
 For example, some apps for medication adherence serve not only as pill 
reminders, but also allow the patient to nominate a “support network” who will also receive notifications if a 




Furthermore, older patients with multimorbidity may benefit more from broader apps, not focused on single 




Other health domains 
Three studies were identified using wearables to detect and prevent accidents related to living with chronic 
diseases. These included fall detection, apnoea detection, and assessing balance for people with Parkinson’s 
disease in their home setting.
101-103
 These pilot studies demonstrated the feasibility of these interventions. 
 
4.3. Past failures 
 
 A study evaluated smartphone apps claiming to detect skin cancer based on pictures of moles and 
found out that three of the apps missed melanoma between 30% and 90% of the time, while only 




4.4. Past successes 
 
 Although apps are currently available across the full spectrum of the patient journey, wellness apps 
predominate, whereas self-diagnosis, filling prescriptions and medication compliance seem to have 
the lowest numbers of apps developed to date.
27
 IMS report found that only 159 apps linked to 
sensors, most of them were fitness and weight apps; Fewer than 50 of those 159 apps were related 




 One of the most advanced apps for chronic disease management and remote monitoring, 
approved by the FDA, is the WellDoc Diabetes Manager software. In the initial clinical trial of 
WellDoc the intervention group showed improved self-care in diet, medication, and exercise 
compared to the control group receiving usual care. Furthermore, 84% patients in the intervention 
group had medications titrated or changed by their healthcare provider compared to controls.
106
 A 
following trial of WellDoc showed a statistically significant decrease in A1c values for intervention 
patients compared to the standard care control group.
106
 The study therefore demonstrates that it 
is possible to improve treatment outcomes with mobile phone and web portal communications 
when used by both patients and their HCPs. 
 
 WellDoc Diabetes Manager exemplifies several success principles
28
: it is integrated into existing 
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with the Electronic Health Record (EHR); it provides intelligent guidance for users and real time 
alerts based on data inputted; it is clinician-friendly, providing clinicians with clear actionable data 
that they can use as a basis for recommendations; it is socialised and interactive, providing personal 
coaching, direct physician support, and caregiver linkage; it is outcome-oriented and cost-effective, 
as demonstrated in trials; it is engaging, enabling patients to configure settings, messaging, 
tonality, and interaction modes. 
 
 The University of Auckland conducted a randomised smoking cessation clinical trial with 1700 
smokers and found that those who received the supportive text messages successfully quit smoking 
at more than twice the rate (28% compared with 13%) of those in the control group. New Zealand’s 




 Bayer has developed a tool that multiple sclerosis patients can use to track their medications, and 




 ‘My Health Matters’, an app from Merck for HIV patients to chart symptoms and adherence to their 




4.5 Mobile apps endorsed by government and non-profit chronic disease groups in Australia 
 
A summary of mobile apps available specifically for Australians is presented in Appendix B. 
 
 There were six mobile apps from the Federal level government (www.australia.gov.au/about-
government/apps). One was to keep track of medicines (Medicine List+); one was to access, add 
and view information about a child’s health records (My Child’s eHealth Record); one was for 
management of post-traumatic stress disorder (PTSD) and prevention of further stress (PTSD Coach 
Australia); two were to encourage smoking cessation (NoSmoke and Quit for You-Quit for Two); 
one was to locate and find information about health providers and hospitals (NHSD – Find a Health 
Service); and one was to educate parents about otitis media. 
 
 From the State government, three apps concerned fitness and exercise promotion (Daily PA, Health 
& Fitness Age Challenge Application, and Walk to School). Two apps were to provide information 
about harmful effects of UV light and promote prevention behaviours such as wearing sunscreen 
(Sun Effects Booth, SunSmart). Better Health Channel provides medical and health information, such 
as first aid procedures. It also provides health and nutritious recipes and personalised health alerts 
and notifications for heat, UV, smog and pollen. 
 
 From the non-profit chronic disease groups as indicated by the Australian Institute of Health and 
Welfare (www.aihw.gov.au/chronic-diseases/), we retrieved 13 health mobile apps.  
 
 Below is a summary of the apps for each chronic disease: 
 Cardiovascular disease (one app to manage medicines, blood pressure and cholesterol. Also 
possible to learn about heart attack warning signs and what to do) 
 Cancer (one app from Cancer Council to inform and promote protection against sun exposure. 
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 Diabetes (two apps retrieved. One provides resources and information for meal planning and 
health articles, as well as contact details for healthcare professionals. The other app allows 
recording of blood glucose levels, daily diet, exercise and medication lists and reminders) 
 Mental health (there were six mindfulness apps. These apps provide meditation, and give 
information and resources about how to control everyday stress and anxiety, as well as how to 
recognise the physical symptoms of stress. One app was designed for management of 
Alzheimer’s disease; it provides a guide about healthy lifestyle and better self-care behaviours) 
 Respiratory diseases (one app was for management of Asthma. It also included information 
about what to do in case of an emergency by providing easy access to First Aid for asthma 
instructions in the phone app) 
 No apps were found for chronic kidney diseases, musculoskeletal conditions and oral health. 
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5  Discussion 
There is a growing body of evidence regarding the feasibility and efficacy of mHealth interventions in the 
prevention and self-management of chronic diseases.  
 
Question 1: Benefits of using mHealth technologies to support chronic disease management  
 
Studies involving the use of mHealth technologies to support chronic disease management have been 
conducted in several health domains: diabetes, cardiovascular diseases, chronic lung diseases (i.e. COPD, 
asthma), mental health, and osteoarthritis. Although SMS was the most common mode of delivery in earlier 
mhealth studies, the most recent ones involved the use of more innovative platforms, such as mobile 
applications, sensors, and wireless devices. 
 
The majority of mHealth interventions to support chronic disease management seem to involve a great 
variety of tasks, such as inform, instruct, record, display, guide, remind/alert, and communicate. 
The majority of studies regarding mHealth for chronic disease management focused on diabetes (two meta-
analysis and 10 systematic reviews). The two meta-analyses in patients with diabetes showed improvements 
in glycaemic control through the use of mobile phones, SMS, internet, and/or wireless devices. The 10 
systematic reviews of mHealth interventions for diabetes self-management showed mixed results for the 
various outcomes assessed (e.g. BMI, weight, glycaemic control, cholesterol, self-management behaviours, 
self-efficacy, and exercise). The remaining studies, mostly systematic reviews, showed mixed results for a 
variety of outcomes in several health domains. 
 
Finally, the majority of the analysed studies did not take into account the costs associated with providing 
the intervention. Only two studies mentioned cost issues; one concluded that the particular intervention 
being provided was not cost-effective. 
 
Question 2: Benefits of using mHealth technologies to track health behaviours for prevention 
purposes  
 
Evidence on the efficacy of mHealth interventions to track and promote healthy lifestyle behaviours is 
growing. Three meta-analyses of interventions involving SMS, mobile apps, PDAs, and remote or web 2.0 
technologies showed significant improvements in physical activity measures and/or weight loss outcomes. 
Two meta-analyses evaluated the effectiveness of mobile phone interventions for smoking cessation and 
found significant results. One meta-analysis combined studies for separate outcomes, namely two RCTs for 
medication adherence and three RCTs for vaccine attendance, having found statistically significant results 
for the latter. 
 
The mHealth technologies utilised for behaviour change included (in descending order of frequency): SMS, 
apps, self-tracking devices, wearable devices and sensors. There was little integration of these interventions 
with clinical care. 
 
Seven systematic reviews included studies where behaviours were tracked with the use of sensors and other 
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not easy to objectively assess the effect of these technologies, for two main reasons: most interventions 
involved several other aspects in addition to wireless self-tracking; and most systematic reviews did not 
provide separate analysis for primary studies involving these kinds of technologies. Indeed, bundle of 
features seems to be important to achieve behaviour change (e.g. self-monitoring followed by personalised 
feedback), and most interventions employ feature bundles, making an objective evaluation of their effect 
more complex. 
 
Features in an mHealth intervention that are important for uptake and impact include: tailoring and 
personalisation, being integrated in a health system (and not a standalone system), offering a bundle of 
features that facilitate behaviour change, use of theories or proven behavioural change strategies, and 
consideration of mHealth treatment fidelity strategies.  
 
There is a paucity of evidence regarding cost-effectiveness. 
 
Question 3: Influence of demographic and socio-economic factors on the benefits of mHealth  
 
Demographic and socio-economic factors seem to influence both the adoption and the effectiveness of 
mHealth interventions. The most common aspects influencing adoption and use of mHealth technologies 
include the following: cost, access to the technology/internet, ease of use, perceived benefit, 
computer/mobile phone experience, literacy, level of personalisation/tailoring of the intervention, presence 
of feedback from healthcare providers, convenience, technical problems, and security issues.  
 
Low literacy levels can significantly influence the impact of mHealth, especially when the 
technology/intervention is not tailored to the specific needs of the population. One example is the use of 
alternative mechanisms for information input in order to avoid the use of written text in populations with 
low levels of literacy. Additionally, there is evidence that training and support in using the technology may 
increase its uptake and use. 
 
Question 4: Strategies to operationalise the use of mHealth technologies for chronic disease 
management and prevention purposes  
 
There is a paucity of evidence regarding strategies to operationalise the use of mHealth technologies for 
chronic disease management and prevention, and the majority of information in this area comes from grey 
literature. 
 
One of the greatest barriers to mHealth uptake in healthcare seems to be the existence of competing health 
system priorities, combined with the lack of evaluation studies and cost-effectiveness analysis to guide 
decisions. Strategies to increase uptake of mHealth will likely need to address the main barriers for each of 
the stakeholders in this process: payers, providers and, most importantly, patients.  
 
Intervention features associated with increased satisfaction and/or adherence include: interactive 
approaches, user-friendliness, time required to use the application, automatic and wireless transmission of 
data from wearables and other devices, variety of educational and motivational content with tailored or 
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Regarding apps, many authors consider that several aspects will be important to facilitate their uptake, 
namely: payer and provider recognition of the potential role of apps in healthcare; creation of 
security/privacy guidelines and policies that protect personal health information; reimbursement and 
supporting policies; integration of apps with other health IT systems; curation and evaluation of healthcare 
apps to guide both patients and clinicians and an infrastructure for app prescribing (i.e. an ‘app formulary’). 
 
Future studies should aim at incorporating the RE-AIM framework (Reach, Effectiveness, Adoption, 
Implementation, Maintenance)
107,108
 to better plan and evaluate their interventions, aiming at the future 
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6  Conclusions 
Mobile phones have several characteristics that make them an attractive tool for the prevention and self-
management of chronic conditions: they are portable and ubiquitous; they are personal, making it 
possible to target interventions to specific individuals; they are connected, being able to provide direct 





Of all the mHealth technologies, SMS is the most prevalent in the literature, and the one with the strongest 
evidence of effectiveness. Furthermore, interventions based on SMS are generally the simplest and lowest 
cost to develop and have the potential for reaching the largest possible audience.  
 
Although a dose-response for SMS-interventions cannot be identified from the present literature, 
interventions using as little as four text-messages per week have been shown to be effective in improving a 
variety of outcomes.
45
 Additionally, personally tailored and interactive interventions seem to be more 
efficacious, especially when the users are able to choose when to receive messages.
109
 Indeed, a meta-
analysis of text messaging interventions to promote antiretroviral therapy adherence showed that larger 
effects were present when interventions: 1) had SMS sent less frequently than daily, 2) supported 
bidirectional communication, 3) included personalised message content, and 4) were matched to 




Interventions with more innovative technologies, such as those involving smartphone apps and/or wearable 
devices, remain mostly seen in feasibility and usability studies, with few published randomised controlled 
trials evaluating their effectiveness. However, these interventions seem promising in promoting long-term 
engagement, especially when involving three key components: 1) habit formation; 2) social aspects (e.g. 




Overall, mHealth interventions seem to be able to promote significant improvements in glycaemic control 
(for diabetes patients), as well as in physical activity, weight loss, and smoking cessation, among other 
outcomes. However, the benefits seem to be dependent on the characteristics of the intervention (e.g. 
bundle of features, use of behaviour change theories, ‘stickiness’) and the specific patient population (e.g. 
age, digital literacy). 
 
One important aspect for the success of mHealth interventions is their integration in healthcare, whereby 
they are able to function as part of a service (and not as a standalone system). Nevertheless, one of the 
greatest barriers to mHealth uptake in healthcare seems to be the existence of competing health system 
priorities, combined with the lack of evaluation studies and cost-effectiveness analysis to guide decisions. 
 
Therefore, in order to improve the uptake and impact of an mHealth service, the following elements are 
important for consideration: 1) the mHealth component is integrated into a health service (and not as a 
standalone system); 2) there is a bundle of features to facilitate action (e.g. decision support, followed by 
task support); 3) the design incorporates appropriate use of theories and behavioural change strategies; 4) 
there are strategies in place to maintain participant interest and minimise dropout; and 5) there are plans to 
ensure mHealth service fidelity (i.e. the accurate delivery, receipt, and enactment of the service).
.111,112
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In the end, strategies to increase uptake of mHealth will likely need to address the main barriers for each of 
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8  Appendices 
Appendix A: Systematic search of mHealth literature across five databases  
 
Databases: Pubmed, Embase, Scopus, CINAHL, Cochrane Library 
 
Time period: From 2005 to current 
 
Limits: English and Humans 
 
("Chronic Disease"[Mesh] OR "Self Care"[Mesh] OR "Diabetes Mellitus"[Mesh] OR 
"Mental Health"[Mesh] OR "Risk Reduction Behavior"[Mesh] OR "Sedentary 
Lifestyle"[Mesh] OR "Asthma"[Mesh] OR "Obesity"[Mesh] OR "Exercise"[Mesh] OR 
"Cardiovascular diseases"[Mesh]) AND (“Mobile Health” OR "Text 
Messaging"[Mesh] OR mHealth* OR m-health* OR mobile* OR wearable* OR 
pervasive OR “Mobile applications”[Mesh] OR “Cell Phones”[Mesh]) 
 
MeSH terms: “Mobile applications” includes: Application, Mobile; Applications, Mobile; Mobile 
Application; Mobile Apps; App, Mobile; Apps, Mobile; Mobile App; Portable 
Electronic Apps; App, Portable Electronic; Apps, Portable Electronic; Electronic App, 
Portable; Electronic Apps, Portable; Portable Electronic App; Portable Electronic 
Applications; Application, Portable Electronic; Applications, Portable Electronic; 
Electronic Application, Portable; Electronic Applications, Portable; Portable 
Electronic Application; Portable Software Apps; App, Portable Software; Apps, 
Portable Software; Portable Software App; Software App, Portable; Software Apps, 
Portable; Portable Software Applications; Application, Portable Software; 
Applications, Portable Software; Portable Software Application; Software 
Application, Portable; Software Applications, Portable 
 
“Cell phones” includes: Phone, Cell; Phones, Cell; Cellular Phone; Cellular Phones; 
Phone, Cellular; Phones, Cellular; Telephone, Cellular; Cellular Telephone; Cellular 
Telephones; Telephones, Cellular; Cell Phone; Transportable Cellular Phone; 
Cellular Phone, Transportable; Cellular Phones, Transportable; Transportable 
Cellular Phones; Smartphone; Smartphones; Smart Phones; Smart Phone; Phone, 
Smart; Phones, Smart; Mobile Phone; Mobile Phones; Phone, Mobile; Phones, 
Mobile; Mobile Telephone; Mobile Telephones; Telephone, Mobile; Telephones, 
Mobile; Car Phone; Car Phones; Phone, Car; Phones, Car; Portable Cellular Phone; 
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Appendix B: Mobile apps endorsed by government and non-profit chronic disease groups in 
Australia  
 




Medicine List + National 
Prescribing Service 
Ltd 
The more medicines you take, the more difficult it can be to 
remember important information about them. A medicines list 
can be a useful way to keep all the information about your 
medicines together 
 
Keeping an up-to-date list of all the medicines you take will help 
you to get to know your medicines, get better results from your 
medicines and enjoy better health 
 
App features: 
 Barcode scan your medicines or select from a pick list 
 Follow links to more medicine and health information on the 
NPS MedicineWise website 
 Edit, update and print an easy-to-read ‘Medicines List’ 
 Set alerts for medicine doses and for refilling prescriptions 
 Add details about your health conditions 
 Record details about your medical tests and results, and 
have your results graphed 








This app is for Australian healthcare consumers with children 
under the age of 14 years. It allows parents and authorised 
representatives to access the child’s personally controlled 
electronic health (eHealth) record to add and view information 
about the child’s development 
 
The app lets you add and view a range of information, such as 







Helps you understand and manage the symptoms of post-
traumatic stress disorder, or PTSD. It is not designed as a stand-
alone treatment – ideally, it is a tool to use as part of your 
treatment 
 
PTSD Coach Australia is an app that helps people understand 
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The app is based on the latest scientific understandings of PTSD, 
and was modified from the US Department of Veterans' Affairs 
PTSD Coach app 
 
Quit for You – 





Provides support and encouragement to help you give up 
smoking if you are pregnant or planning to be 
 
Part of government advertising campaign intended to 
encourage mothers from a ‘diverse background’ to quit smoking 
 
Includes tracker/educational component for baby progress and 
money saved, etc. Includes Quitline connection and other 
support options 
 





The National Health Services Directory (NHSD) helps you find 
location and opening hours for GPs, pharmacies, emergency 
departments and hospitals, when and where you need them 
 
Talking book/ 





Basic ear health information presented in style of an interactive 
children’s book, read in English or many Indigenous languages 
NoSmokes.com.au Menzies School of 
Health Research 
Designed for use by Aboriginal and Torres Strait Islander people, 
including mobile software, videos, and online games. Hosted 
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Department of National Parks 
Recreation Sport and Racing 
 Tool for teachers and coaches who lead PA and 
sport sessions whether these be in the classroom, 
schoolyard or local sporting club 
 The aim of this resource is to get school children 
active, and to instil in them a positive attitude 






The State of Queensland 
(Department of Health)  
Health & Fitness 
 Everyday things to improve the way you look and 
feel 
 Get reminders, tips and facts about the areas you 
need to focus on 






Queensland Health  Shows how your current behaviour in the sun can 
damage your face in the future 
 Allows users to check the daily UV Index forecast for 
their local area to see how strong the sun is and 
when the UV Index reaches 3 and sun protection is 
required 
 
VacciDate The State of Queensland 
(Department of Health)  
 Tool to help you manage your child's vaccination 
schedule in Queensland for children up to four 
years of age 
 Enter appointment dates for vaccinations; receive 
reminders at one month, one week, one day and 
one hour before the next vaccination is due or next 
appointment is scheduled; and store a record of 







Department of Health 
(Victoria) 
 Providing easy to understand and reliable 
information  
 First aid procedures for a wide range of common 
injuries  
 Healthy and nutritious recipes 
 Urgent medical help and advice contacts 
 Personalised health alerts and notifications for heat, 








 The SunSmart app lets you know when you do and 
don't need sun protection and when it's safe to get 
some sun for vitamin D, making it easier than ever 
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Teen Drinking 
Law 
Department of Health 
(Victoria) 
 Provides information about risks and decisions 
associated with under-age drinking 
 
Walk to School Department of Health 
(Victoria) 
 Encourage regular walking not only in the lead up 
to the day, but beyond, such as: being able to track 
kilometres travelled to and from school, time spent 
walking and the average walking speed in a bid to 
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3. Mobile apps endorsed by non-profit chronic disease groups in Australia 
Chronic disease Organisation name App 
available? 
(Y/N) 
App name App details 
Cardiovascular 
disease 
Heart Foundation Yes My heart, 
my life 
 Manage medicines 
 Manage blood pressure and 
cholesterol 
 Educate about heart attack  
 








 Information and contacts for 




No   
National Breast 
Cancer Foundation 
No   
Ovarian Cancer 
Australia 
No   
Prostate Cancer 
Foundation Australia 





No   
Diabetes Diabetes Australia Yes Diabetes 
Australia 
app 
 Meal planning, latest news and 
health articles 
 Easy access to contact details for 
healthcare professionals 








 Record blood glucose levels 
(BGLs) 
 Record daily diet and exercises 
 Inbuilt food, exercise and 
medication lists 
 Add food, exercise and 
medications to the lists 
 View graphs of BGLs, Glycaemic 
Load and calories burned over 
time 
 Send graphs via email 
 Save doctors’ prescriptions and 
add new medications 
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Diabetes SA No   
Diabetes NSW No   
Diabetes Victoria No   
Mental health beyondblue 
 
Smiling Mind 
Yes Mind the 
Bump 
 Free Mindfulness Meditation App 
to help individuals and couples 
support their mental and 
emotional wellbeing in 
preparation for having a baby 
and becoming new parents 
 
beyondblue Yes The 
Check-in 
 Helps build a conversation plan 
to support a friend, including 
where the conversation will 
happen, what to ask, what you 
have noticed and what you can 
do to support 
 Provides links to a range of 
online and phone services 
appropriate for young people in 
Australia 
 Provides tips and advice from 
young people who have been 
through these conversations with 
friends 
 
ReachOut Yes ReachOut 
WorryTim
e 
 Control everyday stress and 
anxiety by acting as a place to 
store daily worries – “Choose a 
time in the day that works best for 
you, and WorryTime will send you 
an alert when it's time to think 
about what's been stressing you 
out“ 
 
ReachOut Yes ReachOut 
Breathe 
 Helps control breath and 
measures heart rate in real-time 
using the phone camera 
 Helps address the onset of 
physical symptoms of stress, like 
shortness of breath, increased 
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 ReachOut Yes Recharge  Personalised six-week program 
that helps improve general health 
and wellbeing by focusing on 
four key areas:  
1. A regular wake and sleep 
time each day achieved 
gradually over six weeks 
2. An alarm clock that triggers 
fun activities designed to get 
people up and out of bed 
3. Increasing exposure to 
daylight early in the day, to 
help reset the body clock 
4. Encouraging increased 
physical activity, especially 
within two hours of waking 
up 
 
Alzheimer’s Australia Yes BrainyApp  Guide on how to live a brain-





Yes High Res  Manage immediate responses to 
stress and help build resilience. 
Musculoskeletal 
conditions 
Arthritis Australia No   
Oral health National Oral Health 
Plan 
No   
Australian Dental 
Association 




Asthma Australia No   
Asthma Council Yes Asthma 
Buddy 
 Record a prevention and relief 
medication plan and reference 
peak flow values 
 Know what to do in case of an 
emergency including easy access 
to the First Aid for Asthma 
instructions 
 Email a PDF copy of your action 
plan (e.g. to the doctor) 




Appendix 1: Papers included for Question 1 – What is the evidence regarding the benefits of using mHealth technologies to support chronic disease 
management? 
 











Results and main findings* 
(only statistically significant 











SMS +/- internet 
 










Combined results show 
improvements in glycaemic 
control for the intervention, 










Mobile phone +/- 
internet, wireless 
devices 











(type 1 and 2) 
Combined results show 
improvements in glycaemic 
control for the intervention, 















(e.g. feedback, goal 
setting; tailoring;  
prompt self-monitoring 
of behaviour; identify 
barriers to 
behaviour/problem 















Combined results show 
improvements in glycaemic 
control for the intervention, 
compared with controls 
 
Mixed results for CVD and chronic 
lung disease management, as well 

















web-based, 3 with 















No difference between 
intervention and control regarding 




















(type 1 and 2) 
Three studies reported 
improvements in glycaemic 
control for the intervention, 
compared with controls 
 
Two studies showed 
improvements in knowledge about 














PDA (+/- internet) 









(type 1 and 2) 
Seven studies with type 2 diabetes 
patients showed improvements in 
glycaemic control for the 











Cell phone Monitoring, SMS, advice 
and self-care 
 







Diabetes Nine out of 10 studies that 
measured haemoglobin A1c 
showed a significant improvement. 
Mixed results regarding other 
outcomes 
High/Moderate 


















phone and other 
wireless devices 
Monitoring of blood 
glucose, pedometers, cell 
phone 
 





18 RCTs  
(1989–2008) 
Diabetes Mixed results for a variety of 
outcomes  
 
Limited to moderate evidence of 












phone + app, 
wireless devices 










Significant improvements in DM-
specific clinical outcomes such as 
blood glucose and A1c were 
reported in 11 out of 26 studies 
 
Significant improvements in 
clinical outcomes such as blood 
pressure, weight, and lipid profile 
were reported in seven out of 13 
CVD-related studies 
 
Three out of six RCTs in chronic 
lung disease reported 











SMS +/- internet 
+/- wireless 
devices 









Six out of 17 studies focusing on 
diabetes found improvements in 
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One study focusing on asthma 






















Mobile phone messaging had few 
direct impacts on health outcomes 
related to the management of 
diabetes and hypertension 
 
One study involving asthma 
patients found significant 
improvements on peak expiratory 



























Significant improvements in 
medication compliance, asthma 
symptoms, HbA1C, stress levels, 
smoking quit rates, and self-
efficacy 
High/Moderate 









Process improvements were also 
reported (e.g. lower failed 
appointments and quicker 
diagnosis and treatment) 
 













Two studies in arthritis patients 
showed significant improvements 
in daily step counts between 
intervention and control groups 
 
Mixed results for the five 
cardiovascular disease studies, 10 

















Patients in the intervention group 
received four semi-personalised 
SMSs per week for six months, and 
the majority reported the text 
messages to be useful (91%), easy 
to understand (97%), and 
appropriate in frequency (86%) 
 
At six months, levels of Low-
Density Lipoprotein Cholesterol 
(LDL-C) were significantly lower in 
intervention participants, with 
concurrent reductions in systolic 
BP and BMI, significant increases 
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One study found no statistically 
significant differences on asthma 
symptom scores, asthma-related 
quality of life, visits no the ED or 
hospital admissions 
 
The other study found statistically 
significant improvements in 
asthma-related quality of life, lung 
















Mobile technology did not 
improve asthma control or 
increase self-efficacy compared 
with paper based monitoring 
when both groups received clinical 

























Studies used mobile phones to 
target smoking cessation. In all, 
the intervention participants were 
significantly more likely to achieve 
abstinence 
 
Three studies used handheld 
computers targeting anxiety 
 
Improvement in anxiety in only 
High 





















Mental health No significant differences between 
intervention and control groups 
regarding depressive symptoms, 
stress, anxiety, and substance use 
 
High 




RCT Smartphones with 
internet enabled 







psychoeducation in intervention 
group (smartphone) reduced 
depressive symptoms at 12 week 
compared to control group 
(paper-and-pencil). The effect was 


























Mixed results from low quality 
studies on the effectiveness of 
ambulatory treatment for anxiety, 
and diabetes management, among 
other outcomes 
Low 
















18 of the 29 studies were 
efficacious in improving 
medication adherence rates or 
biomarkers after receiving text 
messages (P<0.05), while 11 
studies reported no difference 
 
High 











SMS, app reminders, healthy 
lifestyle reminders, or 
both 
 







five studies on HIV-infected 
patients, in eight of the studies on 
patients with other chronic 
diseases, and in one study 






Meta-analysis SMS Inform, instruct, 
remind/alert, 
communicate 





SMS can support therapy 
adherence 
 
Larger effects when interventions 
were sent less frequently than 
daily, supported bidirectional 
communication, included 
personalised message content, 
and were matched to participants’ 




























Mixed results but some evidence 
supporting the use of text 
messaging as a tool to improve 
adherence to medication and 























Hamine et Systematic SMS, mobile Inform, instruct, record, 107 studies Adherence Of the 27 RCTs that measured the High 




















effect of mHealth on adherence 
behaviours, a significant difference 
between groups was observed in 





RCT Mobile phone - 
SMS 
Adherence to taking 















difference between intervention 



















Results and main findings* 
(only statistically significant 
results are reported) 
Grade of 
evidence 












Mobile technology did not 
improve asthma control or 
increase self-efficacy compared 
with paper based monitoring when 
both groups received clinical care 
to guidelines standards 
 


















Average acceptable fees (in USD) 
of the service system: u-health 
device, $421.28; home visit, 
$21.53/visit; tele-education, 
$0.53/min or 















Diabetes T1DM patients would need to pay 
€10 per month for a data bundle 
on their mobile phone contract in 
order to use a mobile-enabled 
application to enter diabetes-
Low 




related data for healthcare 
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Results and main findings* 
(only statistically significant 


































Mental health Ambulatory monitoring of 
symptoms showed excellent test-
retest reliability and sensitivity to 
change  
 





















Mobile sensing of sociability and 
activity was well correlated with 








Appendix 2: Papers included for Question 2 – Benefits of using mHealth technologies to track health behaviours for prevention purposes 
 










Results and main findings* 
(only statistically significant 
















(e.g. feedback, goal 
setting; tailoring;  
prompt self-monitoring 
of behaviour; identify 
barriers to 
behaviour/problem 























No statistically or clinically 
significant changes in weight for 
trials using SMS messages to 
reduce calorie intake and increase 
physical activity (standard mean 
difference [SMD]) or for trials 
using application software to 
reduce calorie intake 
 
SMS-based smoking cessation 
interventions more than doubled 
biochemically-verified smoking 
cessation at six months 
 
Three trials reported statistically 
significant increases in adherence 
to antiretroviral medication with 






















Moderate to large effect for 
pedometer steps 
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software (e.g. provide information, 
motivational messages, 
reminders; SMS to self-
report or provide 
feedback) 
 
participants interventions delivered via mobile 
phone 
  
Effects were non-significant for 
moderate-vigourous PA duration, 
and PDA delivered interventions. 
Small number of studies and 
considerable heterogeneity 
 
Little rigorous study of the 






















(e.g. interaction in group 
or individual meetings; 
counselling and advice; 
self-directed or 
prescribed exercise; 
home based or facility 
based exercise; and 











The effect of the interventions on 
cardiovascular fitness at one year 
(two studies, 444 participants) was 
positive and moderate (SMD 0.40; 
95% CI 0.04 to 0.76; high quality 
evidence) 
 
The effect of the interventions on 
self-reported PA at one year (nine 
studies, 4547 participants) was 
positive and moderate (SMD 0.20; 
95% CI 0.11 to 0.28; moderate 
quality evidence)  
 
One study reported positive results 
at two years (SMD 0.20; 95% CI 
0.08 to 0.32; moderate quality 
evidence) 
Very high 









Meta-analysis  Smartphones, 
PDAs, iPods, Mp3 
players, and other 
modern portable 
devices  




(e.g. SMS, MMS, 
calculator, storage of 
food photos, 
gamification, social 
networking, goal setting, 
tailoring, podcast, audio 









Overall medium effect size for 
weight loss of 0.43 (95% CI 0.252 
to 0.609), favouring the 
intervention 
 
Mixed results for reductions in 
BMI, waist circumference, body fat 
percentage, as well as 
improvements in dietary intake 






Meta-analysis Activity trackers 
 









(21 studies – 
type 2 
diabetes;  







interventions have beneficial 
effects on physical activity, HbA1c, 
systolic blood pressure, and BMI in 
patients with type 2 diabetes 
 


















(e.g. encouragement of 














Of the 12 studies that used mobile 
technologies to influence physical 
activity (PA) behaviour, nine 
reported significant changes in PA 
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monitoring and 
measuring of physical 














(text, pager or 
mobile phone)  
 




messages, prompts for 
self-monitoring of food 








Strong evidence across several 
high-quality RCTs that weight loss 
occurs in the short-term with 
mobile technology interventions 
(75% studies support use of 
mobile interventions for BMI 25–
39.9) 
 
Moderate evidence for the 
medium-term (no studies with 
follow-ups >12 months) 
 
High 













information such as 
weight or physical activity 
via SMS to researchers; 
diet and exercise self-
monitoring; goal 






Of the 14 interventions in this 
review, 11 showed a statistically 
significant effect on weight loss, 
diet or exercise, and one study 
showed a statistically significant 






















(e.g. SMS as a primary 
intervention was often 
supported by education, 
in-person weigh-ins, or 




recording calorie intake 
and consumption; daily 
exercise; showing daily 











Five out of the seven studies 
reported statistically significant 
results in at least one outcome. 
However, studies were low to 
moderate in quality and the 
majority of significant findings 
were not between intervention and 





























Fitness Only five studies assessed physical 
activity intervention effects, 
showing mixed results  
 
Four studies (three pre–post and 
one comparative) reported 
physical activity increases 
 
Moderate 




RCT Mobile phone + 
sensors 
Weight control and 
exercise; weight loss; use 







Positive results as the intervention 
group had superior results in 
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 weeks 
 















































Other (2)  
 
Three studies focusing on weight 
loss found significant 
improvements between groups 
 
Seven out of eight studies 
focusing on smoking cessation 
revealed statistically significant 





























One study focusing on physical 
activity found a statistically 
significant difference in percent 
body fat lost 
 
Four smoking cessation studies 
reported significantly greater 
success in behaviour change 
among the intervention group 
participants who received a 
smoking cessation-related 
educational intervention delivered 
High/Moderate 













Meta-analysis Mobile phone Mobile phone use to 
promote smoking 
cessation 





 Evidence of short-term effect of 







RCT Mobile phone 8 counselling sessions 

















Individuals living with HIV are 
receptive to, and can be helped by, 
smoking cessation treatment 
 
Counselling delivered by mobile 
phone can significantly increase 

























Mixed results from low-quality 
studies on the effectiveness of 
ambulatory treatment for healthy 
eating, physical activity, weight 
loss, smoking cessation, eating 
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Appendix 3: Papers included for Question 3 – Influence of demographic and socio-economic factors on the benefits of mHealth 
 










Results and main findings* Study 









SMS +/- internet 
 











Younger patients with shorter 
diabetes duration seem to benefit 
more from the intervention 
 
High 






Mobile phone +/- 
internet, mobile 
device 









(type 1 and 2) 
Greater improvement in glycaemic 
control for patients with type 2 













PDA (+/- internet) 









(type 1 and 2) 
One study reported a significant 
reduction in HbA1c only in the 












Diabetes Men and women differed in 
regards to self-efficacy, knowledge 
gained, and desired content in 
future mHealth interventions 
 
Low 







model + phone + 






In the subgroup of intervention 
patients with low literacy or high 
Moderate 


















information needs there was an 
8.8mm Hg reduction in average 
systolic blood pressure and a 
significantly greater proportion of 
intervention than control patients 
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No significant difference in clinic 
attendance nor in healed 
perforation, middle ear 
discharge or perforation size 







Survey + focus 
groups + 
interviews 
Mobile phones Monitoring, self-
management 




Mental health Attitudes toward the use of mobile 
phones for the monitoring and 
self-management of depression, 
anxiety, and stress appear to be 
positive as long as privacy and 
security provisions are assured, 
and as long as the intervention is 
not intrusive and is easy to use, 










Mobile phone + 
internet + 
accelerometer + 
diary app  
 










Participants find the mobile-phone 
modalities practical and easy to 
use, and preliminary results show 











Little evidence pertaining to 
effectiveness, with current 
interventions being very limited in 
scope and not widely adopted 
 
Low 
























General 692 studies Other (chronic 
conditions) 
The systems examined depended 
on the active engagement of 
consumers and patients and the 






















Racial/ethnic minorities, older 
adults, persons with lower health 
literacy, and persons with more 
depressive symptoms appeared to 






 Review Mobile phone  - Other  
(elderly) 
mHealth is being increasingly used 
as a way to support health 
management and self-monitoring, 
but elderly people still face some 














Monitoring - Other (falls) Older adults appear to be 
interested in using such devices 
although they express concerns 
over privacy and understanding 
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Appendix 4: Papers included for Question 4 – Strategies to operationalise the use of mHealth technologies for chronic disease management and prevention 
purposes 
 
4.1. Operational steps and strategies to increase uptake 
Grey literature 
Title Source Year 









The Economist – Intelligence Unit 2015 








Implementing a mobile health solution in the clinical setting – White Paper Series
30
 Seamless MD 
 
2014 





mHealth in an mWorld – how mobile technology is transforming healthcare
26





























SMS +/- internet 
 








Diabetes Effects on glycaemic control were 
greater for interventions that used 








Review Mobile phone or 
PDA +/- PC, blood 
glucose monitor 
Self-management 28 studies Diabetes Ease of use and data presentation 
(fast analysis of results) were 
important aspects for adoption 
  
Time required to use the 
application is an important 
element for success 
 
Automatic and wireless 
transmission of blood glucose data 










App Goal setting, self-tracking 
calorie intake, tailored 
support  









Trial retention was 93% in the 
smartphone group, 55% in the 
website group, and 53% in the 
diary group at six months 
 
Adherence was statistically 
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app group compared with the 















Fitness Participants found the Fitbit to be 
unobtrusive and easy to use and 
reinforced increasing their physical 
activity; however, success using the 
watch was highly variable 
 
Low 











29 studies Medication 
adherence 
Negative studies tended to have 
more basic and repetitious content 
with a simple medication 
reminder, while positive studies 
delivered a variety of educational 
and motivational content with 









PDA Ecological momentary 
intervention  





Mental health Participants stated that EMI 
sessions were helpful, user-
friendly, and engaging, and 
reported satisfaction with the 
timing and burden of sessions, as 
well as the method of delivery 
 
High adherence (participants 

















Asthma Patients rated the technology 
positively and considered that it 
may help clinicians to provide care, 
especially during acute attacks 
Low 









Although rated similarly, 
professionals were more sceptical 
about benefits  
 
Both professionals and patients 






















Asthma Participants considered that 
mobile phone-based monitoring 
systems can facilitate guided self-
management although, 









Meta-analysis  Remote or web 
2.0 technologies 
(e.g. internet 










participants (in groups or 
individuals, one-off or 




home based or facility 
based exercise; 












The most effective interventions 
applied a tailored approach to the 
type of physical activity and used 
telephone contact to provide 
feedback and to support changes 




















activity with automated 
or personalised SMS 
 
Self-monitoring and 
measuring of physical 















Mixed results for usability 
 
The studies that reported 
acceptability assessment outcomes 
revealed that on-body sensing 
systems, mobile journals, and SMS 
messaging, received positive 
acceptability ratings from 
participants 
 
One study that used a mobile 
journal and three studies that used 
SMS messaging determined that 
these mobile technologies are 
feasible ways to deliver physical 
activity interventions. 
Text messaging or smartphone 
applications are well accepted by 
participants 
 
The nine studies that reported 
significant changes in physical 
activity or sedentary behaviour 
employed SMS communication to 
promote physical activity, physical 
activity self-monitoring through 























information such as 
weight or physical activity 
via SMS to researchers; 
diet and exercise self-
monitoring; goal 
reminders or plan 
reminders; tailored 
feedback on physical 






Seven studies measured feasibility 
and acceptability of SMS as a 
mode for weight loss 
interventions. SMS was found 
feasible and acceptable in all seven 
studies 
 
One SMS per day may be 
appropriate in helping motivate 
people to engage in weight loss 
































Periodic messaging has positive 
short-term effects across a number 
of health behaviours and across 
media and frequency 
 
Of the 55 original research articles 
using periodic messaging, 42 
reported significant differences in 
short-term behavioural-change 
between intervention and 
comparison groups across all 
behaviours, with the exception of 
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behaviour of iodine consumption 
 
Three studies additionally 
suggested long-term behavioural 
changes 
 
Given that the included 
interventions varied by many 
factors, including behaviour, 
prompt, use of feedback, goal-
setting, and theoretical models, it 
was difficult to form a conclusive 
judgment regarding which 







Review iPhone apps  Smoking cessation apps N=47 Substance use 
(smoking 
cessation) 
iPhone apps for smoking cessation 
rarely adhere to established 










logger on a waist 




Assess balance and 
















Home testing is feasible on 
patients with Parkinson’s Disease 
 
Low 



























Other (sleep) Demonstrated technical feasibility 
– the wearable apnoea detection 












Use motion signals 
detected by the mobile 





Other (falls) Fall detection using a mobile 
phone is technically feasible – the 

















Health apps have a high rate of 
dropouts with 26% being used 
only once and 74% being 
discontinued by the tenth use 
 
79.9% of respondents preferred an 
app that would analyse the health 
information they were logging and 
provide personal feedback  
 
For health apps to be successful 
patient adherence tools, they must 





85 MHEALTH TECHNOLOGIES FOR CHRONIC DISEASE PREVENTION AND MANAGEMENT | SAX INSTITUTE 
















Fitness Measurements recorded using 
mobile health apps are mainly 
entered manually by the user. This 
allows for inaccurate data entry, 
which could compromise its 
reliability  
 
Self-motivation to record data 
over a longer period can be a 
challenge without the involvement 










4.3 Past failures 
Study 
author  























Dermatology Sensitivity of the four tested apps 
ranged from 6.8% to 98.1%; 
specificity ranged from 30.4% to 
93.7%; positive predictive value 
ranged from 33.3% to 42.1%; and 
negative predictive value ranged 
from 65.4% to 97.0% 
 
The highest sensitivity for 
melanoma diagnosis was observed 
for an app that sent the image 
directly to a dermatologist  
 
The lowest sensitivity was 
observed for apps that used 
automated algorithms to analyse 
images 
 
The performance of apps assessing 
melanoma risk was highly variable, 
and three out of four apps 








87 MHEALTH TECHNOLOGIES FOR CHRONIC DISEASE PREVENTION AND MANAGEMENT | SAX INSTITUTE 












Tools related to managing alcohol 
craving, monitoring consumption, 
and identifying triggers to drink, 
were rated by participants as 
particularly helpful 
 
There were significant reductions 
in hazardous alcohol use while 
using the system and drinks per 
































Cell phone intervention easy to use 
 
Patients had lifestyle changes and 














Assessment of health 
status and self-care + 
tailored education 
 







Diabetes The system detects abnormal 
glycaemia and blood pressure 
levels that might otherwise go 
unreported, although thresholds 
for clinician notifications might 
require adjustment to avoid 
overloading clinicians  
 
Patient engagement might be 
enhanced by addressing health 







Cross-sectional App Self-tracking 
 
Record, display 
- Fitness Usage data collected from 
myFitnessCompanion from 5500+ 
users between June 2011 and 
January 2012 shows an increasing 






















Mental health  Long-term use of mobile 
technologies to assist in the 
assessment and treatment of 

















Asthma Patients are satisfied monitoring 






Cross-sectional App Coaching 
 









Mental health The app was favourably received Low 











29 studies Medication 
adherence 
Text messaging interventions are 
feasible and acceptable with the 
majority of studies reporting high 
participant satisfaction (>80%) in 





















App designed to facilitate dietary 
and fluid self-monitoring seems to 
be well accepted by users 
Moderate 
  


















Trial retention was 40 out of 43 
(93%) in the smartphone group, 19 
out of 42 (55%) in the website 
group, and 20 out of 43 (53%) in 
the diary group at six months 
 
Adherence was statistically 
significantly higher in the 
smartphone group with a mean of 
92 days (SD 67) of dietary 
recording compared with 35 days 
(SD 44) in the website group and 










usage data + 
survey) 
Mobile app  Monitoring, reminder 
 










The smartphone application 
supporting drug adherence was 
downloaded more than 11,000 
times and it was used regularly by 
chronically ill users over a longer 
period of time 
 
The majority of users were middle-
aged and male 
 
Moderate 
 
 
 
